Update on the diagnosis, treatment, and prognosis of the catastrophic antiphospholipid syndrome (Q37738701)

22 August 2017

1 reference

title

Update on the diagnosis, treatment, and prognosis of the catastrophic antiphospholipid syndrome (English)

1 reference

catastrophic antiphospholipid syndrome

22 August 2017

0 references

diagnosis

0 references

author

Ricard Cervera i Segura

series ordinal

1

object named as

Ricard Cervera

1 reference

22 August 2017

1 February 2010

1 reference

Current Rheumatology Reports

22 August 2017

1 reference

22 August 2017

12

1 reference

22 August 2017

1

1 reference

22 August 2017

70-76

1 reference

https://scigraph.springernature.com/pub.10.1007/s11926-009-0073-6

22 August 2017

0 references

cites work

Is there a microangiopathic antiphospholipid syndrome?

1 reference

12 December 2020

The role of therapeutic plasma exchange in the catastrophic antiphospholipid syndrome

1 reference

12 December 2020

Relapsing catastrophic antiphospholipid syndrome: report of three cases

1 reference

12 December 2020

Long term outcome of catastrophic antiphospholipid syndrome survivors

1 reference

12 December 2020

Catastrophic antiphospholipid syndrome during pregnancy and puerperium: maternal and fetal characteristics of 15 cases

1 reference

12 December 2020

V meeting of the European forum on antiphospholipid antibodies.

1 reference

12 December 2020

Defibrotide mediated inhibition of serotonin, endothelin-I, thromboxane, and serum induced contraction of canine femoral and pulmonary arterial rings

1 reference

12 December 2020

Sustained response to rituximab of autoimmune hemolytic anemia associated with antiphospholipid syndrome.

1 reference

12 December 2020

Catastrophic antiphospholipid syndrome: clues to the pathogenesis from a series of 80 patients

1 reference

12 December 2020

The acute respiratory distress syndrome in catastrophic antiphospholipid syndrome: analysis of a series of 47 patients

1 reference

12 December 2020

Intestinal involvement secondary to the antiphospholipid syndrome (APS): clinical and immunologic characteristics of 97 patients: comparison of classic and catastrophic APS.

1 reference

12 December 2020

Disseminated intravascular coagulation in catastrophic antiphospholipid syndrome: clinical and haematological characteristics of 23 patients

1 reference

12 December 2020

Multiorgan thrombotic disorders in systemic lupus erythematosus: a common link?

1 reference

12 December 2020

Intravenous immunoglobulin: adverse effects and safe administration

1 reference

12 December 2020

Thrombotic microangiopathic haemolytic anaemia and antiphospholipid antibodies

1 reference

12 December 2020

Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation

1 reference

12 December 2020

Rituximab treatment for resistant antiphospholipid syndrome.

1 reference

12 December 2020

Catastrophic antiphospholipid syndrome

1 reference

12 December 2020

Catastrophic antiphospholipid syndrome and sepsis. A common link?

1 reference

12 December 2020

Validation of the preliminary criteria for the classification of catastrophic antiphospholipid syndrome

1 reference

12 December 2020

Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines

1 reference

12 December 2020

The catastrophic antiphospholipid syndrome

1 reference

12 December 2020

The role of malignancies in patients with catastrophic anti-phospholipid (Asherson's) syndrome

1 reference

12 December 2020

Microangiopathic antiphospholipid-associated syndromes revisited new concepts relating to antiphospholipid antibodies and syndromes

1 reference

12 December 2020

The clinical spectrum of catastrophic antiphospholipid syndrome in the absence and presence of lupus.

1 reference

12 December 2020

Catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of a series of 280 patients from the "CAPS Registry".

1 reference

12 December 2020

Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients

1 reference

12 December 2020

Mortality in the catastrophic antiphospholipid syndrome: Causes of death and prognostic factors in a series of 250 patients

1 reference

12 December 2020

Nuclear factor kappa B: a pivotal role in the systemic inflammatory response syndrome and new target for therapy

1 reference

12 December 2020

Microvascular and microangiopathic antiphospholipid-associated syndromes ("MAPS"): semantic or antisemantic?

1 reference

12 December 2020

Ancrod in systemic lupus erythematosus with thrombosis. Clinical and fibrinolysis effects

1 reference

12 December 2020

Catastrophic antiphospholipid syndrome: treatment, prognosis, and the risk of relapse

1 reference

12 December 2020

Pathology and pathogenesis of vascular injury in systemic lupus erythematosus. Interactions of inflammatory cells and activated endothelium

1 reference

12 December 2020

Catastrophic antiphospholipid syndrome. Clinical and laboratory features of 50 patients

1 reference

12 December 2020

10.1007/S11926-009-0073-6

Identifiers

DOI

1 reference

22 August 2017

1 reference

PubMed ID

20425537